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THE EFFECT OF CHOLESTEROL-RELATED KNOWLEDGE ON PATIENTS’ 
ABILITY TO REACH TARGET CHOLESTEROL LEVELS. 
Jeffrey A. Seiden, Susan Cheng, and Harlan M. Krumholz. Section of Cardiology, 
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT. 
The purpose of this study is to determine whether patients with coronary artery 
disease (CAD) are more likely to reach their target cholesterol levels if they possess an 
understanding of cholesterol’s relationship to heart disease. Utilizing a patient population 
with known CAD who were admitted to the hospital for a cardiac event or preventive 
intervention, we analyzed subjects’ baseline responses to the open-ended question, “What 
can you tell me about the relationship of cholesterol to heart disease?” Patients were 
divided into one of two groups based on their responses: one with knowledge, Group A 
(n=561), and one without knowledge, Group B (n=177). Using bivariate and multivariate 
statistical analysis, we determined that age >65 years and lack of any college education 
were independent predictive factors for lacking sufficient cholesterol-related knowledge, 
as defined in this study. Further analysis demonstrated that patients in Group A were 
more likely to reach their target level for low-density lipoprotein (LDL) after one year of 
follow-up (71.4% in Group A versus 58.3% in Group B, p=0.0Q3). In addition, those 
patients in Group A were more likely to reach their target for all cholesterol parameters 
(total cholesterol, LDL, and high-density lipoprotein (HDL)) after one year (49.9% 
versus 40.4%, respectively, p=0.04). These results indicate that while educational efforts 
after hospitalization for CAD may be effective in increasing target compliance, not all 
patients respond equally to such interventions. A baseline understanding of cholesterol 
and its relationship to cardiac disease is predictive for success in reaching one’s 
cholesterol target values one year after hospital admission. Efforts by primary care 
physicians, especially directed toward those patients over 65 years old and those without 
any college education, may help improve the population’s baseline understanding of 
cholesterol, thus leading to improved outcomes in patients diagnosed with CAD. 
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For nearly twenty years, elevated plasma cholesterol has been considered a 
significant risk factor for coronary artery disease (CAD), thus contributing greatly to the 
leading cause of mortality in the United States. In 1985, the National Heart, Lung, and 
Blood Institute (NHLB1) created the National Cholesterol Education Program (NCEP) in 
an attempt to increase the American population’s awareness of cholesterol, in addition to 
improving the treatment and control of elevated cholesterol levels.(1,2) Since the launch 
of such initiatives, several studies have investigated their efficacy in improving 
cholesterol-related knowledge and hypercholesterolemia control in the population. These 
studies, which relied on knowledge surveys of the general adult population, demonstrated 
a significant improvement in the awareness of high blood cholesterol and its negative 
health effects.(3,4) 
There has been no published research regarding cholesterol knowledge among 
patients with known CAD. In 1994, the NCEP published its second Adult Treatment 
Panel goals, which outlined recommendations for the control of blood cholesterol levels 
in patients with established CAD.(5) Allison et al., however, found that only 39% of 
patients with known CAD were reaching their target for low-density lipoprotein (LDL) 
cholesterol levels.(6) Many variables have been investigated as independent factors in a 
patient’s ability to reach the target cholesterol level. Drug therapy, diet, and exercise 
have all been shown to be significant in determining a patient’s success in achieving this 
goal. 
There has been very little investigation in the area of cholesterol knowledge and 
its link to achieving target cholesterol levels. This is an important and clinically 
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significant question, since compliance with target cholesterol levels, especially in patients 
with known CAD, is so poor. Many studies have demonstrated the importance of diet, 
exercise, and lipid-lowering medications in reducing the risk of adverse cardiac events. 
Primary care physicians have focused on these factors in their attempts to lower their 
patients’ cholesterol levels. They have had some degree of success in these efforts, 
though it is clear that there is much room for improvement. Indeed, some research in 
other areas has demonstrated that the effectiveness of a patient’s attempt to alter his 
lifestyle or behavior depends at least partially on the physician’s ability to help build a 
foundation of knowledge and attitudes that is conducive to change.(7,8) Therefore, a 
focus on improving patients’ knowledge and understanding regarding cholesterol and its 
role in heart disease may assist in increasing the percentage of patients that reach their 
target cholesterol level. As a result, fewer patients will experience adverse cardiac 
events, and fewer preventive interventions, e.g. CABG or PTCA, will need to be 
performed. 
The Reinforcing Education About CHolesterol (REACH) trial was designed to 
assess the efficacy of a nurse-based educational intervention in increasing the percentage 
of patients with known CAD whose LDL levels meet the target established by the NCEP. 
This randomized control trial demonstrated that the educational intervention did not 
significantly improve patient compliance with LDL targets after one year of follow-up. 
However, awareness of LDL targets did improve in the intervention group compared to 
the control group (19.6% vs. 6.7%, p=0.001).(9) General knowledge regarding 
cholesterol and heart disease was not assessed in this study. One question raised by this 
study is whether awareness of one’s goal needs to be paired with an understanding of 
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why lowering one’s cholesterol is important in preventing heart disease. The patients 
enrolled in the REACH trial were interviewed at baseline to assess their knowledge 
regarding cholesterol and its relationship to heart disease. 
The goal of this project is to determine whether patients with CAD are more 
likely to reach their target cholesterol levels if they possess an understanding of 
cholesterol’s relationship to heart disease. Using the patient population and the data 
collected in the REACH trial, patients’ cholesterol-related knowledge will be analyzed as 
an independent predictive factor in their ability to reach their target levels for blood 
cholesterol. Results of this study may emphasize the importance of patient education in 
the effort to lower patients’ blood cholesterol levels. 
Purpose and Hypothesis 
The purpose of this study is to assess whether patients with CAD are more likely 
to reach their target cholesterol levels if they possess an understanding of cholesterol’s 
relationship to heart disease. This project will detennine if knowledge level is an 
independent predictive factor for reaching target cholesterol levels. Results of this study 
may emphasize the importance of patient education in the effort to lower patients’ blood 
cholesterol levels. 
Our hypothesis is that patients with greater cholesterol-related knowledge are 






Subjects for this study were those enrolled in the REACH trial. Between 
December 1998 and January 2000, consecutive medical patients admitted to Yale-New 
Haven Hospital (YNHH) were screened for participation in the study. Within 24 hours of 
admission, patients were evaluated for evidence of CAD, which was defined as a current 
or past diagnosis of an acute myocardial infarction (AMI), current or past coronary artery 
bypass grafting (CABG), current or past percutaneous coronary intervention (PCI), or 
coronary artery stenosis >70% as documented by cardiac catheterization. Exclusion 
criteria included: age <30years or >80 years, out-of-state residence, terminal illness, 
contraindications to treatment with lipid-lowering medication, residence in a long-term 
care facility, and/or any condition precluding informed consent or the ability to be 
interviewed. Of the 2657 consecutive patients screened, 1469 (52%) were deemed 
ineligible by the above criteria. Another 432 patients were not enrolled due to their 
refusal or discharge prior to being interviewed by research staff. Of the 756 patients 
enrolled in the study, we excluded from this analysis 16 patients aged >80 years, who 
were inadvertently enrolled in the REACH trial, as well as 2 patients whose baseline 
interviews were missing and could not be reviewed. The institutional review board of the 
Yale University School of Medicine approved the study, and all participants gave written 
informed consent for their participation in the study. 
Data Collection 
Patients enrolled in the REACH trial were interviewed by trained research staff a 
mean of 3.7±3.4 days after admission. The standardized interview was designed to assess 
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each patient’s knowledge, attitudes, and behaviors related to cholesterol and CAD. In 
addition, we inquired about socioeconomic status as measured by education level, 
employment status, and occupation. Demographic and clinical data, such as medical 
history, diagnostic tests and procedures, surgical interventions, laboratory data, and 
medications, were collected from each patient’s medical record from the index 
admission. Serum lipid samples were drawn upon enrollment and were analyzed by the 
YNHH laboratory, providing measures of triglyceride, total cholesterol, and high-density 
lipoprotein (HDL) levels. Those patients who had undergone CABG surgery did not 
have baseline serum lipid levels drawn, since they would be artificially low after surgery. 
At the time of each patient’s one-year follow-up appointment, whole blood samples were 
taken using the fmgerstick technique and analyzed by the Cholestech LDX System to 
provide follow-up data for the above measurements. All LDL levels were calculated 
using the Friedewald formula. Patients with triglyceride levels >400 mg/dl did not have 
LDL levels calculated. 
Cholesterol Knowledge Measures 
During the baseline interview, all patients were asked, “What can you tell me 
about the relationship of cholesterol to heart disease?” Patients’ responses tended to fall 
into one of two categories; some patients explicitly addressed the role of high cholesterol 
as a risk factor for heart disease, while others responded by explaining the mechanism by 
which cholesterol leads to heart disease (e.g. “cholesterol clogs the arteries of the heart”). 
Responses in each of these categories were deemed to be equally valid and correct 
answers to the question. As a result, responses were evaluated and scored based on these 
two parameters: the understanding of high cholesterol as a risk factor for adverse cardiac 
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events and the understanding of the mechanism by which cholesterol causes CAD and 
heart disease. 
For this analysis, subjects were divided into two groups, one with knowledge 
(Group A) and one without knowledge (Group B) regarding cholesterol and its 
relationship to heart disease. As illustrated in Figure 2, Group A was defined as those 
subjects who demonstrated an understanding of either risk or mechanism as described 
above, while Group B was defined as those subjects who demonstrated an understanding 
of neither risk nor mechanism. 
Patients were also asked during the baseline interview to report the importance of 
cholesterol control utilizing the question, “Considering all of the things that are going on 
in your life, how important of a priority to you is taking care of your cholesterol level?” 
Subjects were given the choices: extremely important, very important, important, not 
very important, or not important at all. 
Target Cholesterol Levels 
Target cholesterol levels used in the analysis for this study were taken from the 
NCEP Adult Treatment Panel II recommendations for patients with established CAD: 
LDL cholesterol <100 mg/dL, HDL cholesterol >35 mg/dL, and total cholesterol <200 
mg/dL. (5) 
Statistical Analysis 
Statistical analysis was performed primarily by Susan Cheng. We used chi-square 
tests to evaluate bivariate associations between each dependent variable and patient 
demographic and clinical characteristics. Based on clinical relevance and the results of 
bivariate analyses, relevant characteristics (e.g. age >65 years, less than college 
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education, priority < very important) were selected and entered into a logistic regression 
model. To assess the independent relationship of each characteristic with the different 
cholesterol knowledge components, a separate model was constructed for each variable. 
Statistical analyses were conducted with SAS statistical software, version 8.01 (SAS 
Institute Inc., Cary, NC). 
Results 
As illustrated in Figure 1, 738 patients from the REACH trial were divided into 
two groups. Group A, those patients with knowledge about cholesterol, comprised 74.2% 
of the 756 subjects enrolled in REACH, while Group B, those patients without 
knowledge about cholesterol, comprised 23.4%. 18 patients (2.4%) enrolled in the 
REACH trial were not analyzed for this study. 
Cholesterol-related Knowledge 
Table 1 displays selected demographic information for each of the study groups. 
Patients in Group B were older than those in Group A (mean age 65.3 ± 9.8 versus 62.7 ± 
9.6 respectively, p=0.0014) and were more likely to be over 65 years old (59.9% versus 
46.7%, p=0.002). Members of Group B were also more likely to be non-white (14.3% 
versus 8.24%, p=0.018). While mean years of education were similar in both groups 
(13.8 ± 3.2 in Group A versus 12.3 ± 3.3 in Group B, p=0.069), the proportion of patients 
who attended college for any amount of time was significantly greater in Group A than in 
Group B (53.9% versus 35.9% respectively, p=0.001). Both groups were similar with 
respect to gender (27.3% women in Group A versus 34.5% women in Group B, p=0.066). 
Participation in the REACH trial should not have any differential effect on the two 
groups for this study, since a similar proportion of each were randomized to the 
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intervention arm of the REACH study (51% in Group A versus 44.6% in Group B, 
p=0.141). 
As shown in Table 2, patients were similar in their cardiac risk factors, defined by 
the NCEP as older age (men >45, women > 55), history of hypertension, history of 
diabetes mellitus, current smoker, and HDL <35 mg/dL. Those with cholesterol 
knowledge (Group A) were more likely to have had a recent cholesterol test (84.6% 
versus 72.5%, p=0.001), and they were also more likely to be taking a lipid-lowering 
agent (56.1% versus 41.2%, p=0.001). In addition, patients in Group A were more likely 
to report that cholesterol management was “extremely important” or “very important” in 
their lives (75.5% versus 59.9% in Group B, p=0.001). 
Multivariate analysis, illustrated in Table 3, showed that patients aged 65 years or 
older (OR 0.62, 95% Cl 0.43-0.90), patients without any college education (0.68, 0.46- 
0.99), patients not taking a lipid-lowering medication (0.66, 0.45-0.96), and those who 
rated cholesterol management less than “very important” (0.58, 0.32-0.89) were less 
likely to exhibit sufficient cholesterol-related knowledge. 
Cholesterol Target Compliance 
As Table 4 demonstrates, Groups A and B had similar blood cholesterol levels 
(total cholesterol, HDL, and LDL) at baseline. For one year after their index admission, 
all patients in the REACH trial received some degree of education regarding cholesterol 
and heart disease. Those in the control group received the usual and standard care, 
defined by YNHH protocol, which included standard patient education materials, a 
baseline assessment of lipid status, referral to a dietician, and written discharge 
instructions. Further, all patients were given a written summary of their current 
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cholesterol levels, their recommended target levels, and a list of strategies for overall risk 
modification. Those patients randomized to the REACH intervention group experienced 
a more intensive nurse-based educational intervention, including frequent telephone 
contacts and monthly mailings.(9) At the end of one year, Table 5 shows that patients in 
Group A had lower LDL levels (89.1 ± 32.4 versus 95.5 ± 35.2 respectively, p=0.04). 
Values for total cholesterol and HDL were similar between both groups after one year. 
Figure 3 illustrates that a similar proportion of each group was in compliance with 
the NCEP target for LDL (46.5% in Group A versus 46% in Group B, p=0.928) at 
baseline. After one year, however, patients in Group A were significantly more likely to 
meet their LDL target (71.4% versus 58.3% respectively, p=0.003). When measured at 
baseline, the proportion of patients in each group who met the target values for all 
parameters (total cholesterol, HDL, and LDL) was similar (29.1% in Group A versus 
20% in Group B, p=0.117), as shown in Figure 4. Again though, after one year, patients 
in Group A were significantly more likely to be in compliance with all cholesterol targets 
(49.9% versus 40.4% respectively, p=0.04). Multivariate analysis further indicated that 
not having sufficient cholesterol knowledge was a risk factor for failing to meet one’s 
cholesterol targets at one year, independent of other variables such as age and education 
(OR for meeting target 0.60, 95% Cl 0.42-0.87). In addition, female gender was also 
determined to be an independent predictive factor for failing to reach target (OR for 
meeting target 0.52, 95% Cl 0.37-0.73). 
Discussion 
Among those with known CAD, our study demonstrates that 76% of patients 
possess an understanding of cholesterol and its relationship to heart disease. These 

14 
results may reflect the increase in cholesterol knowledge among the general population 
since the inception of the NCEP in 1985.(3,4) Though several studies have previously 
characterized patients’ knowledge of their personal cholesterol levels and targets,(4,10) 
this study attempts to measure patients’ knowledge of the association of elevated blood 
cholesterol with heart disease. The process of quantifying an inherently qualitative 
variable brings with it some degree of subjectivity, which may illustrate one limitation in 
considering the results of this study. Given that, however, our results demonstrate some 
important differences between those patients with sufficient cholesterol-related 
knowledge and those without such knowledge. 
Our findings suggest that elderly patients (age 65 years or older) and those 
without any college education are significantly less likely to possess cholesterol 
knowledge (Table 3). These results echo the work of Cheng et al., which demonstrated 
that these same patient characteristics are also predictive for failing to know one’s 
cholesterol targets.(10) Additionally, patients with known CAD who were not taking 
lipid-lowering medication, as well as those that did not report cholesterol management as 
being at least “very important,” were also less likely to understand the relationship of 
cholesterol and heart disease. Though previous work has shown that males and whites 
have significantly higher knowledge regarding personal cholesterol levels,(11,12,13) our 
results did not support such findings. Previous studies suggest that patient knowledge is 
important in achieving success in changing health-related behaviors and lifestyles.(7,8) 
Thus, identifying patient populations that are likely to lack sufficient cholesterol-related 




Despite increased understanding of cholesterol and heart disease, we found no 
significant difference in cholesterol target compliance between knowledgeable patients 
and their counterparts at baseline (Table 4). These findings suggest that knowledge alone 
does not predict lower cholesterol levels. Lifestyle and behavior modifications such as 
weight loss, diet, and exercise are central to the success of patients’ reaching their 
cholesterol goals. Knowledge and understanding may play a role in a patient’s 
motivation to make these changes. Therefore, one may posit that an increased level of 
understanding at baseline will prepare a patient for the education offered by the physician 
with respect to lifestyle modifications, personal cholesterol levels, and targets. 
Our results demonstrate that after one year, those patients with an understanding 
of cholesterol (Group A) were more likely to reach their target levels for LDL cholesterol 
(Figure 3). While both groups had similar LDL compliance at baseline (46% versus 
46.5%, p=0.928), 71.4% of Group A reached their target after one year, while their 
counterparts in Group B had only 58.3% compliance with their LDL target (p=0.003). 
Similarly, patients with knowledge were more likely to meet all of their cholesterol 
targets (LDL, HDL, and total) after one year than those without knowledge, despite 
having similar compliance with all targets at baseline (Figure 4). 
All subjects in this study, whether randomized to the REACFI intervention group 
or to the REACH control group, were offered substantial guidance and education 
regarding CAD and cholesterol management after their index hospital admission. 
Ultimately, the aim of such time-intensive efforts by physicians is to improve their 
patients’ medical outcomes. Though one year was not a sufficient time to measure our 
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subjects’ medical outcomes, we used cholesterol target compliance as our endpoint 
because these targets are believed to have value in predicting positive outcomes.(2) 
The results of our study demonstrate that, while education and guidance appear to 
be beneficial for all patients with CAD, those patients who possess a baseline 
understanding of cholesterol and heart disease are more likely to translate such 
educational interventions into lifestyle changes that result in lower blood cholesterol 
levels. This underscores the importance of physician-patient interactions, especially in 
the primary care setting. In addition to the education provided by specialists once a 
referral has been made, patients need to be educated about their health and risk factors for 
disease prior to experiencing an adverse event. As our results demonstrate, those patients 
that do receive such education are more receptive to further improvements in cholesterol 
management. 
Since intensive educational efforts by primary care physicians are quite time- 
consuming, it is important for physicians to be able to predict which patient populations 
are more likely to need such interventions. Demographically, our study suggests that 
elderly patients (age >65 years) and those without any college education are more likely 
to lack sufficient cholesterol knowledge (Table 3). Therefore, physicians might choose to 
focus their educational efforts on such patient populations. While patients who were not 
taking a lipid-lowering medication were also less likely to have cholesterol knowledge, 
this finding might be explained by the requisite education that is offered to patients by 
physicians upon beginning a new medication. Our findings also confirm that patients’ 
attitudes toward their health is important in predicting their understanding of cholesterol. 
Not surprisingly, patients with CAD who do not view cholesterol management as at least 
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“very important” are less likely to understand the relationship between cholesterol and 
their disease. Again, this emphasizes the role of primary care physicians in addressing 
patients’ attitudes towards their health via education and guidance regarding the 
modifiable risk factors for cardiac disease. 
In conclusion, compliance with cholesterol targets is quite poor among patients 
with known CAD, despite high cholesterol’s status as a major modifiable risk factor for 
cardiac disease. Educational efforts after hospitalization for CAD may be effective in 
increasing target compliance, though not all patients respond equally to such 
interventions. A baseline understanding of cholesterol and its relationship to heart 
disease is predictive for success in reaching one’s cholesterol target values one year after 
hospital admission. Elderly patients and those without any college education, as well as 
individuals for whom cholesterol management is not a high priority, are less likely to 
possess this baseline understanding. More focused educational efforts and health 
guidance by primary care physicians may be effective in increasing cholesterol 
knowledge in patients at high risk for cardiac disease, which may result in improved 
cholesterol management and better medical outcomes for patients diagnosed with CAD. 
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2657 Patients Screened for Participation in 
REACH Trial 
1188 Patients Eligible for Enrollment 
198 patients refused 
4 231 discharged prior to consent 
-s- 3 not enrolled for other reasons 
432 patients not enrolled 
756 Patients Enrolled 
16 patients over 80 years old 
+ 2 w/o baseline interview data 
18 patients not analyzed 
561 Patients With 177 Patients Without 
Knowledge (74,2%) Knowledge (23,4%) 
Group A Group B 
Figure 1. Subjects from the REACH trial were divided into two groups for the purposes 
of this study. REACH = Reinforcing Education About CHolestcrol, 
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738 Patients Surveyed 
Patients were asked. ’’What can you 
tell me about the relationship of cho¬ 
lesterol to heart disease?1’ 
Responses coded for understanding of 
cholesterol as a risk factor for cardiac 
disease and for the mechanism by which 
cholesterol leads to cardiac disease* 
Risk Only Mechanism Only Both 






Figure 2. Subjects were divided into two groups based upon their understanding of 
cholesterol as it relates to heart disease. Those who understood the mechanism by which 
cholesterol leads to heart disease, as well as those that stated that cholesterol was a risk 
factor for heart disease, were placed into Group A (+ knowledge). Those that understood 
neither risk nor mechanism were placed into Group B (- knowledge). 
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Table 1. Sample Demographics 
Group A Group B p value 
No. of Patients (% of sample) 561 (76.0) 177 (24.0) 
Age (yrs) 62.7 ±9.6 65.3 ±9.8 0.0014 
Age >65 years (%) 46.7 59.9 0.002 
Women (%) 27.3 34.5 0.066 
Non-white race (%) 8.24 14.3 0.018 
Education (yrs) 13.8 ±3.2 12.3 ±3.3 0.069 
Any college education (%) 53.9 35.9 0.001 
REACH Intervention' (%) 51 44.6 0.141 
A = Patients randomized to the educational intervention in the Reinforcing Education 
About Cholesterol trial 
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Table 2. Cholesterol-related Characteristics at Baseline 
Group A Group B p value 
Had Cholesterol Measured in Past 6 
months (%) 
84.6 72.5 0.001 
On Lipid-Lowering Meds (%) 56.1 41.2 0.001 
>2 Cardiac Risk Factors (%) 81.1 84.8 0.272 
Self-reported Priority4 (%) 
Extremely or Very Important 75.5 59.9 0.001 
Less than Very Important 24.5 40.5 
A = Patients’ responses to the question, “Considering all of the things that are going on in 
your life, how important of a priority to you is taking care of your cholesterol level?” 
Answer choices were: Extremely important, Very important, Important, Not very 
important, or Not important at all. 
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Table 3. Associations Between Selected Characteristics and Cholesterol Knowledge 
_Had Cholesterol Knowledge_ 
Patient Characteristic_Adjusted OR_95% Cl_p value 
Age >65 years 0.62 0.43-0.90 0.011 
Female 0.93 0.63-1.38 0.720 
Non-white race 0.68 0.32-1.16 0.158 
Less than College Education 0.68 0.46-0.99 0.044 
No Recent Cholesterol Test 0.72 0.47-1.11 0.136 
Not on Lipid-Lowering Med 0.66 0.45-0.96 0.032 
Cholesterol Mgmt less than 
Very Important 
0.58 0.32-0.89 0.014 
A = Patients who self-reported the priority of cholesterol management to be “important,” 




Table 4. Baseline Cholesterol Levels 
Group A Group B p value 
Total Cholesterol (mg/dL) 180.0 ±45.0 179.3 ±47.3 0.905 
HDL Cholesterol (mg/dL) 40.7 ± 11.6 39.3 ± 11.9 0.362 
LDL Cholesterol (mg/dL) 105.6 ±37.7 104.0 ±36.3 0.754 
LDL at Target (%) 46.5 46 0.928 
All levels at TargetA (%) 29.1 20 0.117 
A = Patients whose total cholesterol, HDL, and LDL meet the target value 
Table 5. Follow-up Cholesterol Levels at One Year 
Group A Group B p value 
Total Cholesterol (mg/dL) 164.7 ±40.9 170.9 ±43.6 0.111 
HDL Cholesterol (mg/dL) 43.6 ± 14.0 43.4 ± 13.9 0.873 
LDL Cholesterol (mg/dL) 89.1 ±32.4 95.5 ±35.2 0.04 
LDL at Target (%) 71.4 58.3 0.003 
All levels at TargetA (%) 49.9 40.4 0.04 
A = Patients whose total cholesterol, HDL, and LDL meet the target value 
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Group A Group B 




Group A Group B 
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